Display options
Cite
Locke CF, Dooley J, Gerber J. Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar. Thromb J. 2005;3(1):4doi: 10.1186/1477-9560-3-4.
Locke, C. F., Dooley, J., & Gerber, J. (2005). Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar. Thrombosis journal, 3(1), 4. https://doi.org/10.1186/1477-9560-3-4
Locke, Charles Fs, et al. "Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar." Thrombosis journal vol. 3,1 (2005): 4. doi: https://doi.org/10.1186/1477-9560-3-4
Locke CF, Dooley J, Gerber J. Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar. Thromb J. 2005 Apr 04;3(1):4. doi: 10.1186/1477-9560-3-4. PMID: 15807892; PMCID: PMC1087886.
Copy Download .nbib Format: NLM
Share it on

Thromb J. 2005 Apr 04;3(1):4. doi: 10.1186/1477-9560-3-4.

Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar.

Thrombosis journal

Charles Fs Locke, John Dooley, Jonathan Gerber

Affiliations

  1. Johns Hopkins Community Physicians Department of Internal Medicine 2360 W, Joppa Rd,, Suite 306 Lutherville, MD 21093 USA. [email protected].

PMID: 15807892 PMCID: PMC1087886 DOI: 10.1186/1477-9560-3-4

Abstract

With the growing use of low-molecular-weight heparins (LMWH) for the treatment and prevention of venous thromboembolism (VTE), it is important to provide an evidence-based comparison with unfractionated heparin (UFH) concerning rates of heparin-induced thrombocytopenia (HIT). Such comparisons are essential in clinical decision-making and cost-modeling. In this paper we review data regarding non-surgical (medical) patients. We conclude that the lack of uniform evaluation and standardized testing for HIT in the current literature precludes making a reliable estimate of the relative risk of HIT in UFH vs. LMWH in either the treatment or prevention of VTE in non-surgical patients. However, current data suggest that the risk of thrombocytopenia and HIT is low and similar for non-surgical patients who receive either LMWH or UFH.

References

  1. N Engl J Med. 1996 Mar 14;334(11):682-7 - PubMed
  2. Br J Haematol. 2002 Sep;118(4):1137-42 - PubMed
  3. Thromb Haemost. 1992 Jul 6;68(1):95-6 - PubMed
  4. N Engl J Med. 1997 Sep 4;337(10):688-98 - PubMed
  5. Ann Intern Med. 2001 Feb 6;134(3):191-202 - PubMed
  6. N Engl J Med. 1997 Sep 4;337(10):657-62 - PubMed
  7. Br J Haematol. 1997 Mar;96(3):442-6 - PubMed
  8. N Engl J Med. 1995 May 18;332(20):1330-5 - PubMed
  9. Ann Intern Med. 2004 Feb 3;140(3):175-83 - PubMed
  10. Haemostasis. 1996 May-Jun;26(3):127-39 - PubMed
  11. N Engl J Med. 1996 Mar 14;334(11):677-81 - PubMed
  12. Chest. 2004 Sep;126(3 Suppl):311S-337S - PubMed
  13. Thromb Res. 1990 Aug 1;59(3):639-50 - PubMed
  14. Arch Pathol Lab Med. 2002 Nov;126(11):1415-23 - PubMed
  15. Haemostasis. 1996;26 Suppl 2:49-56 - PubMed
  16. Arch Intern Med. 2003 Nov 10;163(20):2518-24 - PubMed
  17. Circulation. 1999 May 18;99(19):2530-6 - PubMed
  18. Acta Neurol Scand. 2002 Aug;106(2):84-92 - PubMed
  19. Clin Adv Hematol Oncol. 2003 Jun;1(6):356-64 - PubMed
  20. Semin Thromb Hemost. 2004 Feb;30 Suppl 1:69-80 - PubMed
  21. Thromb Haemost. 1996 Oct;76(4):529-34 - PubMed
  22. N Engl J Med. 1997 Sep 4;337(10 ):663-9 - PubMed
  23. Am Heart J. 2003 Apr;145(4):614-21 - PubMed
  24. Chest. 2004 Sep;126(3 Suppl):172S-696S - PubMed
  25. Arch Intern Med. 2000 Jan 24;160(2):229-36 - PubMed
  26. Blood. 2003 Apr 15;101(8):2955-9 - PubMed

Publication Types